Adient (NYSE:ADNT) Lowered to “Hold” at StockNews.com

Adient (NYSE:ADNTGet Free Report) was downgraded by equities researchers at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Monday.

A number of other equities research analysts also recently weighed in on ADNT. Benchmark upped their price target on shares of Adient from $58.00 to $62.00 and gave the company a “buy” rating in a report on Monday, August 7th. Barclays upped their price target on shares of Adient from $50.00 to $55.00 and gave the company an “overweight” rating in a report on Thursday, August 3rd. Morgan Stanley cut their price target on shares of Adient from $38.00 to $35.00 and set an “underweight” rating for the company in a report on Tuesday, November 14th. Wells Fargo & Company cut their price target on shares of Adient from $49.00 to $41.00 and set an “overweight” rating for the company in a report on Thursday, November 9th. Finally, UBS Group reduced their price objective on shares of Adient from $43.00 to $40.00 and set a “neutral” rating for the company in a research note on Tuesday, October 10th. Two research analysts have rated the stock with a sell rating, four have issued a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $46.25.

Read Our Latest Stock Analysis on ADNT

Adient Stock Performance

Shares of Adient stock traded up $0.10 during trading on Monday, hitting $32.90. 1,358,403 shares of the stock were exchanged, compared to its average volume of 854,398. The stock’s fifty day moving average is $35.33 and its 200 day moving average is $37.49. The stock has a market cap of $3.12 billion, a PE ratio of 15.23 and a beta of 2.77. The company has a debt-to-equity ratio of 0.94, a quick ratio of 0.93 and a current ratio of 1.15. Adient has a 12 month low of $30.10 and a 12 month high of $47.50.

Adient (NYSE:ADNTGet Free Report) last posted its quarterly earnings data on Wednesday, November 8th. The company reported $0.51 earnings per share for the quarter, missing the consensus estimate of $0.52 by ($0.01). The company had revenue of $3.70 billion during the quarter, compared to analyst estimates of $3.78 billion. Adient had a return on equity of 8.14% and a net margin of 1.33%. The business’s revenue for the quarter was up 1.4% compared to the same quarter last year. During the same period in the previous year, the company earned $0.53 EPS. As a group, sell-side analysts anticipate that Adient will post 3.07 EPS for the current year.

Institutional Trading of Adient

Hedge funds have recently made changes to their positions in the stock. Point72 Asset Management L.P. purchased a new stake in shares of Adient in the second quarter worth approximately $27,000. WealthPlan Investment Management LLC raised its position in Adient by 782.8% during the second quarter. WealthPlan Investment Management LLC now owns 1,024 shares of the company’s stock valued at $100,000 after acquiring an additional 908 shares in the last quarter. Headlands Technologies LLC bought a new position in Adient during the third quarter valued at approximately $46,000. AM Squared Ltd bought a new position in Adient during the third quarter valued at approximately $106,000. Finally, Blue Chip Partners LLC bought a new position in Adient during the second quarter valued at approximately $117,000. 91.39% of the stock is owned by hedge funds and other institutional investors.

About Adient

(Get Free Report)

Adient plc, an investment holding company, engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.

Read More

Analyst Recommendations for Adient (NYSE:ADNT)

Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.